Genetic variability in the multidrug resistance associated protein-1 (ABCC1/MRP1) predicts hematological toxicity in breast cancer patients receiving (neo-)adjuvant chemotherapy with 5-fluorouracil, epirubicin and cyclophosphamide (FEC)
Titel:
Genetic variability in the multidrug resistance associated protein-1 (ABCC1/MRP1) predicts hematological toxicity in breast cancer patients receiving (neo-)adjuvant chemotherapy with 5-fluorouracil, epirubicin and cyclophosphamide (FEC)
Auteur:
Vulsteke, C. Lambrechts, D. Dieudonné, A. Hatse, S. Brouwers, B. van Brussel, T. Neven, P. Belmans, A. Schöffski, P. Paridaens, R. Wildiers, H.